# Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa

> **NCT00280657** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 1326 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Valette
- **DRUG:** Diane
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00280657
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03-10
- **Primary completion:** 2005-05-21
- **Final completion:** 2005-05-21
- **Target enrollment:** 1326 (ACTUAL)
- **Last updated:** 2023-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280657, "Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00280657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*